Scott Giacobello
CFO
CFO
CEO
Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Whitehawk Therapeutics, Inc. (WHWK) | Chief Financial Officer | $501,561 | $2,121,941 |
| 2024 | Whitehawk Therapeutics, Inc. (WHWK) | Chief Financial Officer | $483,407 | $807,929 |
| 2023 | Whitehawk Therapeutics, Inc. (WHWK) | Chief Financial Officer | $469,328 | $1,971,183 |
| 2022 | Whitehawk Therapeutics, Inc. (WHWK) | Chief Financial Officer and Former Interim President and Chief Executive Officer | $456,870 | $1,504,666 |
| 2021 | Whitehawk Therapeutics, Inc. (WHWK) | Chief Financial Officer | $75,000 | $4,091,590 |
Executive changes
Earnings-call appearances
-
Whitehawk Therapeutics, Inc. Q4 FY2024 Earnings Call2025-03-18
Whitehawk Therapeutics, Inc. (WHWK)
-
Whitehawk Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-07
Whitehawk Therapeutics, Inc. (WHWK)
-
Whitehawk Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-08
Whitehawk Therapeutics, Inc. (WHWK)